Organization
Galapagos NV
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Galapagos NV
... candidate in cystic fibrosis portfolio Mechelen, Belgium; 21 November 2017; 22.01 CET -Galapagos NV (Euronext & NASDAQ: GLPG) announces initiation of a Phase 1 study ...
... in vitro predictive platform Mechelen, Belgium; 19 November 2017, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) reports positive topline results from its ALBATROSS ...
... Mechelen, Belgium - 3 PM CET Galapagos NV (Euronext & NASDAQ: GLPG) announced additional long-term follow-up data for the ...
... Mechelen, Belgium - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV (Euronext & NASDAQ: GLPG) will show progress in both understanding of ...
... Galapagos presents data from DARWIN 3, other filgotinib studies and Galapagos' GLPG1972 at ...
... the full report: Cipla Inc. Prometic Life Sciences Inc. Bristol-Myers Squibb Company Galapagos NV Merck & Co., Inc. Promedior, Inc. FibroGen, Inc. F. Hoffmann-La Roche ...
... 7.30 CET - At the North American Cystic Fibrosis Conference (NACFC) 2017, Galapagos NV (Euronext & NASDAQ: GLPG) will show progress in both understanding of ...
... very dense; we implemented two prominent strategic partnerships with the biotech company Galapagos and the Tasly Group, one of the top ten pharmaceutical companies in ...
... development worldwide Mechelen, Belgium and Planegg/Munich, Germany; 27 September 2017; 7.30 CET -Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard ...
... further down Mechelen, Belgium; 9 August 2017; 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces positive topline results with its autotaxin ...
... the MOR106 study in atopic dermatitis." "In the first half of 2017 Galapagos continued to invest in its R&D pipeline to produce substantial progress. The ...
... it has exercised its option to develop novel osteoarthritis molecule GLPG1972/S201086 from Galapagos NV (Euronext/NASDAQ: GLPG), thus obtaining global commercial rights outside the U.S. Osteoarthritis ...
... Eloxx Pharmaceuticals Ltd, Enterprise Therapeutics Ltd, Errant Gene Therapeutics LLC, ethris GmbH, Galapagos NV, Gilead Sciences Inc, GlaxoSmithKline Plc, Grifols SA, Grupo Praxis Pharmaceutical SA, ...
... Galapagos NV has announced the initiation of a new Phase II study investigating ...
... Mechelen, Belgium; 5 July 2017; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 study investigating ...
... Eloxx Pharmaceuticals Ltd, Enterprise Therapeutics Ltd, Errant Gene Therapeutics LLC, ethris GmbH, Galapagos NV, Gilead Sciences Inc, GlaxoSmithKline Plc, Grifols SA, Grupo Praxis Pharmaceutical SA, ...
... Discovery Research Taconic and IVAL Enter into Agreement Charles River to Acquire Galapagos' Argenta and BioFocus Service Divisions Simulations Plus Signs 5-Year RCA with the ...
... (USA)Cyprotex PLC. (UK)CeeTox, Inc. (USA)Dassault Systèmes Biovia Corp. (USA)Eurofins ADME BIOANALYSES SAS (France)Galapagos NV (Belgium)Molecular Discovery Ltd. (UK)MultiCASE, Inc. (USA)Optivia Biotechnology (USA)PerkinElmer, Inc. (USA)Pharmaron, Inc. ...
... Mechelen, Belgium; 20 June 2017, 22.00 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from ...
... code 8093710 Mechelen, Belgium; 20 June 2017; 7.30 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces progress made in its R&D strategy ...
... Mechelen, Belgium; 17 May 2017, 22.00 CET; regulated information -- Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors ...
... Mechelen, Belgium; 17 May 2017; 7.30 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces it will hold its Annual R&D ...
... Galapagos NV has announced the acceptance of seven abstracts from several clinical and ...
... Mechelen, Belgium; 15 May 2017, 22.00 CET - Galapagos NV (Euronext & NASDAQ: GLPG) announces the acceptance of seven abstracts from ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤